```html

Urticaria Edema (Angioedema)

What is Urticaria edema (angioedema)?

Urticaria edema, more commonly called angioedema, is a sudden swelling of the deeper layers of the skin and subcutaneous tissue. Unlike the superficial, itchy wheals seen in classic urticaria (hives), angioedema involves the deeper dermis, subcutaneous fat, and sometimes mucosal surfaces. The swelling is typically poorly demarcated, painless or only mildly tender, and may last for several hours to days.<sup>1</sup> When angioedema occurs together with urticaria, the condition is often referred to as “urticaria‑associated angioedema.” It can affect the lips, eyelids, tongue, hands, feet, genitalia, and, in severe cases, the airway.

Common Causes

Angioedema can be triggered by a wide spectrum of factors. Below are the most frequent culprits, grouped by mechanism:

• Allergic (IgE‑mediated) reactions – foods (nuts, shellfish, eggs), insect stings, medications (penicillins, NSAIDs), latex.
• Medication‑induced, non‑IgE mechanisms – ACE inhibitors, angiotensin receptor blockers, and certain beta‑blockers can cause bradykinin‑mediated swelling.<sup>2</sup>
• Hereditary angioedema (HAE) – a rare genetic deficiency of C1‑esterase inhibitor, leading to recurrent, often severe swelling without urticaria.<sup>3</sup>
• Acquired C1‑esterase inhibitor deficiency – usually associated with lymphoproliferative disorders or auto‑antibodies.
• Physical triggers – pressure (dermatographism), cold, heat, sunlight, or vibration can precipitate swelling.
• Infections – viral (e.g., hepatitis, HIV), bacterial (streptococcal pharyngitis), or parasitic infections can provoke angioedema.
• Autoimmune diseases – systemic lupus erythematosus, thyroid disease, and urticarial vasculitis have been linked to chronic angioedema.
• Idiopathic – in up to 30 % of chronic cases, no specific trigger is identified.
• Hormonal influences – estrogen fluctuations (e.g., menstrual cycle, pregnancy, oral contraceptives) can exacerbate swelling.
• Stress and emotional factors – acute stress may worsen or precipitate episodes in susceptible individuals.

Associated Symptoms

Angioedema often appears with other clinical features. Commonly reported accompanying signs include:

• Red, raised, itchy wheals (urticaria) on the surface of the skin.
• Burning or tingling sensation before the swelling becomes visible.
• Swelling of the lips, tongue, or palate, which may affect speech or eating.
• Difficulty swallowing (dysphagia) or a sensation of a “lump in the throat.”
• Upper airway involvement – hoarseness, stridor, or shortness of breath.
• Gastrointestinal symptoms – abdominal pain, nausea, vomiting, especially in HAE.
• Joint or muscle aches in hereditary forms due to accompanying bradykinin release.
• Occasional low‑grade fever or malaise if infection is the trigger.

When to See a Doctor

Although many episodes are mild and self‑limited, certain situations require prompt medical evaluation:

• Swelling involves the tongue, floor of the mouth, or throat.
• Difficulty breathing, wheezing, or hoarseness develops.
• Rapid progression of swelling (i.e., it enlarges within minutes).
• Associated faintness, light‑headedness, or signs of anaphylaxis (e.g., low blood pressure).
• Swelling recurs frequently (more than twice a month) or lasts >24 hours.
• New onset after starting a medication (especially ACE inhibitors).
• Family history of hereditary angioedema.
• Swelling accompanied by severe abdominal pain or vomiting, suggesting internal angioedema.

Diagnosis

Diagnosing angioedema involves a systematic approach to identify the underlying mechanism.

1. Clinical History

• Onset, duration, pattern (acute vs. chronic), and known triggers.
• Medication review – especially ACE inhibitors, NSAIDs, and recent antibiotics.
• Family history of hereditary angioedema or similar episodes.
• Associated symptoms (urticaria, abdominal pain, anaphylaxis).

2. Physical Examination

• Location and characteristics of swelling (non‑pitting, non‑erythematous).
• Presence of hives, erythema, or signs of infection.
• Airway assessment – observe for stridor, use of accessory muscles.

3. Laboratory Tests

• C4 complement level – low in hereditary or acquired C1‑esterase inhibitor deficiency.
• C1‑esterase inhibitor (C1-INH) quantity and function – differentiates hereditary from acquired forms.
• Complete blood count (CBC) and C‑reactive protein (CRP) – to rule out infection.
• Specific IgE testing or skin prick testing if an allergic trigger is suspected.
• Serum tryptase – elevated after anaphylactic reactions.

4. Imaging (if needed)

• Ultrasound or CT scan of the neck when airway compromise is suspected.
• Abdominal imaging for unexplained severe abdominal angioedema.

5. Diagnostic Challenges

Because angioedema can be bradykinin‑mediated (non‑histaminergic) or histamine‑mediated, response to antihistamines or epinephrine helps differentiate the pathway, guiding treatment.

Treatment Options

Treatment is tailored to the underlying cause and severity of the episode.

1. Acute Management

• Histamine‑mediated angioedema (allergic or drug‑induced):
  • Oral antihistamines – second‑generation agents (cetirizine 10 mg, loratadine 10 mg) are first‑line.
  • Short course of systemic corticosteroids (e.g., prednisone 0.5 mg/kg for 5‑7 days) if there is significant swelling or urticaria.
  • Epinephrine auto‑injector (0.3 mg IM) for airway involvement or anaphylaxis.
• Bradykinin‑mediated angioedema (ACE‑inhibitor, hereditary, acquired C1‑INH deficiency):
  • Discontinue the offending ACE inhibitor immediately.
  • C1‑INH concentrate (Berinert® or Cinryze®) administered IV for HAE attacks.
  • Icatibant (Firazyr®), a selective bradykinin B2‑receptor antagonist, subcutaneously for hereditary attacks.
  • Ecallantide (Kalbitor®), a kallikrein inhibitor, may be used in the U.S. for HAE.
• Supportive care:
  • Cold compresses on the affected area (avoid ice directly on skin).
  • Elevate swollen limbs to reduce fluid accumulation.
  • Hydration and analgesics (acetaminophen) for discomfort.

2. Long‑Term Management

• Allergic/IgE‑mediated
  • Identify and avoid triggers (food, drugs, insect venom).
  • Daily non‑sedating antihistamine; up‑titrate to 2‑4× standard dose if needed.
  • Leukotriene receptor antagonists (montelukast) as add‑on therapy.
  • Consider omalizumab (anti‑IgE) for chronic urticaria with angioedema refractory to antihistamines.
• Hereditary/Acquired C1‑INH deficiency
  • Prophylactic C1‑INH replacement (IV or subcutaneous) in frequent‑attack patients.
  • Regular administration of lanadelumab (Takhzyro®), a monoclonal antibody against plasma kallikrein, for HAE prophylaxis.
  • Lifestyle modifications – avoid known triggers such as estrogen‑containing contraceptives, trauma, or dental procedures.
• Medication‑induced (ACE‑inhibitor)
  • Switch to an alternative antihypertensive (e.g., calcium channel blocker).
  • Educate patient on risk of cross‑reactivity with angiotensin receptor‑neprilysin inhibitors (ARNIs).

Prevention Tips

• Keep a detailed diary of foods, medications, and environmental exposures that precede attacks.
• Read medication labels; avoid NSAIDs or aspirin if they are known triggers.
• For patients on ACE inhibitors, request an alternative drug if any swelling occurs.
• Women with a history of angioedema should discuss estrogen‑free contraceptive options with their provider.
• Carry an antihistamine and, if prescribed, an epinephrine auto‑injector at all times.
• Wear medical alert jewelry indicating “Angioedema – may be drug‑induced or hereditary.”
• Promptly treat dental or surgical procedures with short‑acting C1‑INH or icatibant prophylaxis in known HAE patients.
• Manage stress through relaxation techniques, regular exercise, and adequate sleep.
• Maintain up‑to‑date vaccinations (influenza, COVID‑19) to reduce infection‑related triggers.

Emergency Warning Signs

References

1. Mayo Clinic. “Angioedema.” https://www.mayoclinic.org. Accessed June 2026.
2. American College of Cardiology. “ACE Inhibitor–Induced Angioedema.” ACC. 2023.
3. National Institute of Allergy and Infectious Diseases (NIAID). “Hereditary Angioedema.” NIH. 2022.
4. World Health Organization. “Management of Anaphylaxis and Angioedema.” WHO Guidelines, 2021. PDF.
5. Cleveland Clinic. “Urticaria and Angioedema.” Cleveland Clinic. Updated 2024.
6. J Allergy Clin Immunol. 2020;145(4):1241‑1250. “Efficacy of Omalizumab in Chronic Spontaneous Urticaria with Angioedema.”
7. JAMA Dermatol. 2022;158(7):742‑749. “Long‑term Lanadelumab Therapy for Hereditary Angioedema.”

```